Literature DB >> 9600639

Inhibition of striatal dopamine transporter activity by 17beta-estradiol.

K A Disshon1, J W Boja, D E Dluzen.   

Abstract

Striatal synaptosomes from ovariectomized rats were prepared to examine the effect of 17beta-estradiol on [3H]dopamine uptake. Estradiol inhibited [3H]dopamine uptake in a dose-dependent manner, with an IC50 of 7.2 microM. Use of identical concentrations of progesterone had no effect on [3H]dopamine uptake. The effects of estradiol were exerted by decreasing the affinity of the transporter for dopamine, as revealed by a dose-dependent increase in the Km. The Km values for 0 (control), 10, and 100 microM estradiol were 108+/-11 258+/-44 and 415+/-40 nM, respectively, with each of the three concentrations tested being significantly different among each other. No statistically significant differences were obtained for the Vmax, with values for the three increasing doses being 9.2+/-0.8, 8.3+/-0.5 and 7.3+/-0.8 pmol/min per mg protein. These results demonstrate that estradiol, but not progesterone, inhibits striatal dopamine uptake by decreasing the affinity of the transporter for dopamine. Such a mechanism may serve as one of the bases for the modulatory effects of estradiol upon the nigrostriatal dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600639     DOI: 10.1016/s0014-2999(98)00008-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

2.  Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

Review 3.  Neural mechanisms of reproduction in females as a predisposing factor for drug addiction.

Authors:  Valerie L Hedges; Nancy A Staffend; Robert L Meisel
Journal:  Front Neuroendocrinol       Date:  2010-02-19       Impact factor: 8.606

Review 4.  Neuropsychiatric effects of tamoxifen: Challenges and opportunities.

Authors:  Andrew M Novick; Anthony T Scott; C Neill Epperson; Christopher D Schneck
Journal:  Front Neuroendocrinol       Date:  2020-08-18       Impact factor: 8.606

5.  Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women.

Authors:  Charles E Glatt; Angelika D Wahner; Daniel J White; Andres Ruiz-Linares; Beate Ritz
Journal:  Hum Mol Genet       Date:  2005-12-08       Impact factor: 6.150

6.  Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-03-17       Impact factor: 7.853

Review 7.  Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females.

Authors:  Anne Almey; Teresa A Milner; Wayne G Brake
Journal:  Horm Behav       Date:  2015-06-27       Impact factor: 3.587

Review 8.  Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.

Authors:  Christopher L German; Michelle G Baladi; Lisa M McFadden; Glen R Hanson; Annette E Fleckenstein
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

9.  Prenatal protein deprivation alters dopamine-mediated behaviors and dopaminergic and glutamatergic receptor binding.

Authors:  Abraham A Palmer; Alan S Brown; Debbra Keegan; Lara DeSanti Siska; Ezra Susser; John Rotrosen; Pamela D Butler
Journal:  Brain Res       Date:  2008-07-30       Impact factor: 3.252

10.  In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex.

Authors:  B Meyers; M F Kritzer
Journal:  Neuroscience       Date:  2008-12-14       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.